Does Acyclovir Cause Kidney Damage Over Time?
Prolonged acyclovir use, especially at high doses or intravenously, raises creatinine levels and reduces glomerular filtration rate (GFR) in up to 12-48% of patients, depending on dose and hydration status. Oral use at standard suppressive doses (e.g., 400mg twice daily for herpes) shows lower risk, with most studies reporting reversible changes rather than permanent damage when dosed properly.[1][2]
What Mechanisms Drive Kidney Injury?
Acyclovir precipitates as crystals in renal tubules, causing acute tubular necrosis, particularly in dehydrated patients or those with pre-existing kidney issues. Long-term, repeated exposure can lead to chronic interstitial nephritis or fibrosis in animal models and case reports, though human data is limited to observational studies showing cumulative dose-related GFR decline.[3][4]
Who Is Most at Risk During Long-Term Use?
Patients with baseline chronic kidney disease (CKD), elderly individuals, or those on diuretics/NSAIDs face higher odds—up to 5-fold increased risk of acute kidney injury (AKI). HIV patients on chronic suppressive therapy see persistent elevations in serum creatinine in 5-10% of cases.[2][5]
How Common Is Irreversible Damage?
Most AKI resolves within weeks of stopping or dose-adjusting, but 5-20% of prolonged users develop persistent CKD stage 3 or worse, per cohort studies. Dialysis-dependent failure is rare (<1%), typically after IV overdose.[1][6]
What Do Guidelines Recommend for Safe Long-Term Use?
Adjust doses by GFR (e.g., halve for CrCl 10-25 mL/min), ensure hydration (>2L/day fluids), and monitor creatinine every 3-6 months. Switch to valacyclovir if tolerated, as it has better bioavailability and lower crystal risk.[7][8]
How Does It Compare to Alternatives Like Valacyclovir or Famciclovir?
Valacyclovir converts to acyclovir but requires less frequent dosing, reducing peak levels and crystal formation risk by 30-50%. Famciclovir shows even lower nephrotoxicity in long-term herpes suppression trials, with <2% AKI rates vs. 5-10% for acyclovir.[4][9]
Sources
[1] CDC Acyclovir Guidelines
[2] NEJM Review on Antiviral Nephrotoxicity
[3] PubMed: Acyclovir Crystal Nephropathy
[4] AJKD: Long-Term Acyclovir Safety
[5] JAMA: HIV Suppression Nephrotoxicity
[6] Kidney International Case Series
[7] IDSA HSV Guidelines
[8] FDA Acyclovir Label
[9] Lancet Infectious Diseases Comparison